Lopez-Bertoni H, Lal B, Li A, Caplan M, Guerrero-Cázares H, Eberhart C G, Quiñones-Hinojosa A, Glas M, Scheffler B, Laterra J, Li Y
Hugo W Moser Research Institute at Kennedy Krieger, Baltimore, MD, USA.
Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Oncogene. 2015 Jul 23;34(30):3994-4004. doi: 10.1038/onc.2014.334. Epub 2014 Oct 20.
Cancer stem-like cells represent poorly differentiated multipotent tumor-propagating cells that contribute disproportionately to therapeutic resistance and tumor recurrence. Transcriptional mechanisms that control the phenotypic conversion of tumor cells lacking tumor-propagating potential to tumor-propagating stem-like cells remain obscure. Here we show that the reprogramming transcription factors Oct4 and Sox2 induce glioblastoma cells to become stem-like and tumor-propagating via a mechanism involving direct DNA methyl transferase (DNMT) promoter transactivation, resulting in global DNA methylation- and DNMT-dependent downregulation of multiple microRNAs (miRNAs). We show that one such downregulated miRNA, miRNA-148a, inhibits glioblastoma cell stem-like properties and tumor-propagating potential. This study identifies a novel and targetable molecular circuit by which glioma cell stemness and tumor-propagating capacity are regulated.
癌症干细胞样细胞代表低分化的多能肿瘤增殖细胞,它们对治疗抗性和肿瘤复发的贡献不成比例。控制缺乏肿瘤增殖潜能的肿瘤细胞向具有肿瘤增殖能力的干细胞样细胞表型转化的转录机制仍不清楚。在这里,我们表明重编程转录因子Oct4和Sox2通过一种涉及直接DNA甲基转移酶(DNMT)启动子反式激活的机制,诱导胶质母细胞瘤细胞成为干细胞样细胞并具有肿瘤增殖能力,导致多个微小RNA(miRNA)的全基因组DNA甲基化和DNMT依赖性下调。我们表明,一种这样下调的miRNA,即miRNA-148a,可抑制胶质母细胞瘤细胞的干细胞样特性和肿瘤增殖能力。这项研究确定了一种新的、可靶向的分子回路,通过该回路可调节胶质瘤细胞的干性和肿瘤增殖能力。